Armstrong Shaw Associates Inc. CT decreased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.1% during the third quarter, according to its most recent filing with the SEC. The firm owned 20,212 shares of the healthcare conglomerate’s stock after selling 215 shares during the period. UnitedHealth Group accounts for about 4.6% of Armstrong Shaw Associates Inc. CT’s portfolio, making the stock its 6th largest position. Armstrong Shaw Associates Inc. CT’s holdings in UnitedHealth Group were worth $5,377,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC grew its position in shares of UnitedHealth Group by 5.1% in the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after buying an additional 2,981,233 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after buying an additional 39,480 shares during the last quarter. Jennison Associates LLC grew its position in shares of UnitedHealth Group by 12.0% in the 2nd quarter. Jennison Associates LLC now owns 6,616,652 shares of the healthcare conglomerate’s stock worth $1,623,329,000 after buying an additional 710,745 shares during the last quarter. Morgan Stanley grew its position in shares of UnitedHealth Group by 5.2% in the 2nd quarter. Morgan Stanley now owns 5,498,557 shares of the healthcare conglomerate’s stock worth $1,349,017,000 after buying an additional 269,652 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. grew its position in shares of UnitedHealth Group by 2.8% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 4,019,885 shares of the healthcare conglomerate’s stock worth $986,239,000 after buying an additional 108,052 shares during the last quarter. 85.45% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages have recently issued reports on UNH. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research report on Wednesday. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. BMO Capital Markets lifted their price objective on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, October 18th. Argus lifted their price objective on shares of UnitedHealth Group to $285.00 and gave the stock a “buy” rating in a research report on Thursday, October 18th. Finally, Oppenheimer lifted their price objective on shares of UnitedHealth Group from $276.00 to $295.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 17th. Two equities research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $289.86.

In other UnitedHealth Group news, CEO Steven H. Nelson sold 26,033 shares of the business’s stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $270.65, for a total transaction of $7,045,831.45. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Kenneth Irwin Shine sold 163 shares of the business’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. In the last three months, insiders have sold 69,731 shares of company stock worth $18,584,675. 0.87% of the stock is owned by insiders.

NYSE:UNH opened at $260.55 on Thursday. The company has a market cap of $255.95 billion, a price-to-earnings ratio of 25.87, a P/E/G ratio of 1.53 and a beta of 0.78. UnitedHealth Group Inc has a twelve month low of $208.48 and a twelve month high of $278.00. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the consensus estimate of $3.30 by $0.11. The company had revenue of $56.56 billion for the quarter, compared to the consensus estimate of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. UnitedHealth Group’s revenue was up 12.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.66 EPS. On average, equities research analysts expect that UnitedHealth Group Inc will post 12.81 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 1.38%. The ex-dividend date of this dividend is Friday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 35.75%.

ILLEGAL ACTIVITY NOTICE: “Armstrong Shaw Associates Inc. CT Sells 215 Shares of UnitedHealth Group Inc (UNH)” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.dailypolitical.com/2018/11/22/armstrong-shaw-associates-inc-ct-sells-215-shares-of-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Depreciation

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.